BRISBANE, Australia and EAGAN, Minn., March 02, 2022 (GLOBE NEWSWIRE) — Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) announces the Company has entered a binding agreement to place 1,840,000 new Ordinary Shares (New Shares) raising USD 20 million ($A 28 million) to Perceptive Life Sciences Master Fund, […]
Financial
Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the expansion of its Scientific Advisory Board (SAB) with four newly appointed cardiology and RNA drug development experts. Johann Bauersachs, MD; Perry Elliott, MD; Gerasimos Filippatos, MD, PhD; and Barry […]
Rapid Medical Announces Eitan Havis as International President
Mr. Havis will Lead Commercialization from Europe to Asia YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International. Mr. Havis will oversee the commercial expansion of the company’s advanced neurovascular technologies to treat hemorrhagic and ischemic stroke patients in Europe, […]
HeartFlow Announces CEO Transition
John Farquhar Appointed CEO, John Stevens to Become Vice Chair, Board of Directors MOUNTAIN VIEW, Calif., March 01, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that John Farquhar has been appointed President and Chief Executive Officer, effective March 1, 2022. Mr. Farquhar has […]
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
MINNEAPOLIS, March 01, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the fourth quarter and full year ended December 31, 2021, which included the following highlights: Generated $1.6 million in total revenue for the fourth quarter 2021, 19.6% below the prior-year period and a 20% […]
Amarin Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Go-to-Market Strategy in U.S. to Optimize Provider Engagement and Drive Demand for VASCEPA® European Expansion Strategy On Track with Reimbursement Negotiations and Launch Preparations for VAZKEPA Underway in Multiple Markets Plans for Regulatory Filings for Approval of VASCEPA in Several Additional Countries in 2022 Company to Host Conference Call Today at […]
SUPIRA MEDICAL, A SHIFAMED PORTFOLIO COMPANY, CLOSES $30M IN AN OVERSUBSCRIBED SERIES C FINANCING
Company to Advance its Next Generation Percutaneous Ventricular Assist Device LOS GATOS, Calif., Feb. 28, 2022 /PRNewswire/ — Supira Medical, Inc., a Shifamed portfolio company that is focused on developing a next-generation solution for temporary mechanical circulatory support, announced today the closing of $30M in Series C financing. Led by Cormorant Asset Management and The […]
Semler Reports Fourth Quarter and Year-to-Date 2021 Financial Results
2021 HIGHLIGHTS compared to 2020: — Annual revenues increased by 37% — Net income increased by 23% — Cash at December 31, 2021 increased to $37.3 million from $22.1 million SANTA CLARA, Calif., Feb. 28, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical […]
The Israeli start-up CVAid raises $4 million, including investment by Philips for its AI-based platform for diagnosis of stroke
TEL AVIV, Israel, Feb. 28, 2022 /PRNewswire/ — The Israeli digital health company CVAid Medical, which has developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of capital raising from Philips together with Sanara Capital. The Israeli Rad Biomed investment fund led […]
Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook
SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2021. “Our team and physicians had a tremendous impact […]
Recent
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
Popular
- No commented posts yet